La vendita allo scoperto per Athira Pharma dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Athira Pharma. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Athira Pharma (NASDAQ:ATHA) Azioni, Report sulle vendite allo scoperto

Athira Pharma

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.

Athira Pharma Inc

Atha Energy Corp

Athabasca Minerals Inc

ATHABASCA OIL CORP by Athabasca Oil Corp.

Athabasca Oil Corp

In the current market session, United States Cellular Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USM#NYSE">USM</a>) stock price is at $60.80, after a 1.62% decrease. However, over the past month, the company's stock spiked by 5.15%, and in the past year, by 37.70%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1730482234_0.png" alt="Past Year Chart" />

<h3>Comparing United States Cellular P/E Against Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 19.65 in the Wireless Telecommunication Services industry, United States Cellular Inc. has a higher P/E ratio of 74.46. Shareholders might be inclined to think that United States Cellular Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1730482234_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

News

Intraday Update

Markets

Price Over Earnings Overview: United States Cellular

Piper Sandler analyst Matthew Clark maintains CVB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVBF#NASDAQ">CVBF</a>) with a Overweight and lowers the price target from $25 to $23.

Price Target

Analyst Ratings

CVBF

Piper Sandler Maintains Overweight on CVB Financial, Lowers Price Target to $23

Barclays analyst Andrew Lazar maintains Kraft Heinz (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>) with a Equal-Weight and lowers the price target from $36 to $35.

Barclays Maintains Equal-Weight on Kraft Heinz, Lowers Price Target to $35

RBC Capital analyst Brad Heffern maintains Mid-America Apartment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAA#NYSE">MAA</a>) with a Sector Perform and lowers the price target from $169 to $165.

RBC Capital Maintains Sector Perform on Mid-America Apartment, Lowers Price Target to $165

Goldman Sachs analyst Kash Rangan maintains Weave Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WEAV#NYSE">WEAV</a>) with a Neutral and raises the price target from $13 to $14.5.

WEAV

Goldman Sachs Maintains Neutral on Weave Communications, Raises Price Target to $14.5

RBC Capital analyst Brad Heffern maintains NNN REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NNN#NYSE">NNN</a>) with a Sector Perform and lowers the price target from $48 to $45.

RBC Capital Maintains Sector Perform on NNN REIT, Lowers Price Target to $45

Goldman Sachs analyst Chris Shibutani maintains United Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTHR#NASDAQ">UTHR</a>) with a Neutral and raises the price target from $243 to $302.

UTHR

Goldman Sachs Maintains Neutral on United Therapeutics, Raises Price Target to $302

RBC Capital analyst Arun Viswanathan maintains O-I Glass (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OI#NYSE">OI</a>) with a Outperform and lowers the price target from $18 to $16.

RBC Capital Maintains Outperform on O-I Glass, Lowers Price Target to $16

Goldman Sachs analyst Brian Lee maintains Stem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STEM#NYSE">STEM</a>) with a Neutral and lowers the price target from $0.75 to $0.65.

STEM

Goldman Sachs Maintains Neutral on Stem, Lowers Price Target to $0.65

Jim Cramer, the well-known stock market commentator, set social media buzzing this week after he tweeted about Reddit&#8217;s stellar earnings report, putting it on par with Google&#8217;s results.&nbsp;
Cramer <a href="https://x.com/jimcramer/status/1851547876419051779">acknowledged</a> that it&#8217;s difficult to determine which of the two tech behemoths made more money, referring to Reddit&#8217;s revenues as &#8220;amazing.&#8221; Considering Google&#8217;s dominance in the tech industry, this is quite the endorsement.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">It&#39;s tough to tell which one is better -Reddit or Google. I am not kidding, Reddit was amazing
&mdash; Jim Cramer (@jimcramer) <a href="https://twitter.com/jimcramer/status/1851547876419051779?ref_src=twsrc%5Etfw">October 30, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul>
<li>This Adobe-backed AI marketing startup went from a $5 to $85 million valuation working with brands like L'Oréal, Hasbro, and Sweetgreen in just three years –<a href="https://www.benzinga.com/money/rad-ai"> here's how there's an opportunity to invest at $1,000 for only $0.50/share today.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target –<a href="https://www.benzinga.com/money/mode-mobile-2"> You can still get 4,000 of its pre-IPO shares for just $1,000</a></li>
</ul>
Cramer's tweet may seem surprising, especially as Google has long been one of the world's tech giants. However, it shows how Reddit has evolved into a successful company that can contend for investors&#8217; and users&#8217; attention.
Both businesses produced impressive third-quarter earnings that surpassed forecasts, which prompted the comparison. Despite an anticipated loss of 8 cents per share, Reddit&#8217;s performance has been good, <a href="https://www.benzinga.com/news/earnings/24/10/41633983/reddit-stock-is-ripping-higher-wednesday-whats-happening">with earnings of 16 cents per share</a>.&nbsp;
Revenue also surpassed estimates, coming in at $348.4 million, and the company&#8217;s gross margin improved to 90.1%. Perhaps the most noteworthy figure was the 47% rise in daily active users to 97.2 million. For the first time since its March IPO, Reddit turned a profit.
See Also: The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a>
Wall Street was also captivated by Reddit&#8217;s optimistic outlook. The company expects fourth-quarter revenue between $385 million and $400 million, outpacing the analyst estimate of $356.7 million.&nbsp;
As a result of Reddit&#8217;s impressive performance, <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41631795/reddit-remains-a-favorite-for-wall-street-after-emphatic-beat-and-raise-in-q3">analysts promptly modified their projections</a>. Roth MKM increased from $89 to $116, Piper Sandler from $70 to $115, and&nbsp;
Needham increased its price objective from $85 to $120.
However, Google also had a fantastic quarter. The tech behemoth <a href="https://www.benzinga.com/markets/equities/24/10/41629264/alphabets-earnings-rally-pushes-magnificent-7-market-cap-to-record-16-8-trillion-10-tech-heavy-e">beat analyst projections</a> of $1.83 per share with earnings of $2.12 per share. Cloud revenue increased 35% year over year to $11.4 billion, contributing to the $88.27 billion in revenue. Advertising revenue also rose, beating estimates at $65.85 billion.&nbsp;
Trending: If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?
The appeal of new AI features like AI Overviews, which currently serve 1 billion users each month, and the robust growth of Google&#8217;s cloud business was highlighted by CEO Sundar Pichai. With CFO Anat Ashkenazi declaring a $13 billion budget for the upcoming quarter, Google intends to continue making significant investments in AI and data technology.
Despite the positive numbers from both companies, what really stands out is the sentiment surrounding Reddit. Jim Cramer&#8217;s excited tweet suggests a change in public opinion. Reddit is becoming more popular as a strong platform with genuine commercial value in addition to being a social community. The company&#8217;s notable revenue growth, increased user base, and enhanced profitability are creating a stir.
Read Next:
<ul>
<li>‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a></li>
<li>With over 7.8K investors including Meta, Google, And Amazon Execs — this AI Startup's valuation has skyrocketed from $5 million to $85 million in just three years. <a href="https://www.benzinga.com/money/rad-ai">Be an early investor with just $1,000 for only $0.50/share today.</a></li>
</ul>

Startups

'I'm Not Kidding, Reddit Was Amazing' — Jim Cramer Compares Reddit To Google, Saying Choosing Between Them Isn't Easy

Goldman Sachs analyst Kate McShane maintains Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) with a Buy and raises the price target from $127 to $159.

Goldman Sachs Maintains Buy on Sprouts Farmers Market, Raises Price Target to $159

RBC Capital analyst Deane Dray reiterates Eaton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) with a Outperform and maintains $374 price target.

Reiteration

RBC Capital Reiterates Outperform on Eaton Corp, Maintains $374 Price Target

Solana's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) ecosystem showed notable financial and institutional growth in the year&#8217;s third quarter, securing $173 million in new funding across 29 projects despite a slowdown in the number of funding rounds, according to a new Messari report.
What Happened: This 54% quarter-over-quarter increase represents the highest quarterly funding total since Q2 2022, highlighting investor confidence in Solana&#8217;s infrastructure and DeFi solutions, Messari writes.
A notable aspect of Solana's growth is its appeal to institutional giants. 
&#8220;Solana has caught the attention of major players like Visa, PayPal, and Franklin Templeton, each of whom expanded operations on Solana this quarter," the report states. 
With Solana now holding $123 million in tokenized treasuries, it ranks third globally in this category, trailing only Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) and Stellar, and edging closer to rivaling Ethereum's dominance. 
This stronghold in tokenized treasuries reflects a "shifting landscape" in blockchain adoption, with more financial entities recognizing the unique offerings of Solana's network.
Messari&#8217;s report further highlights key advancements in Solana's infrastructure. 
The Q3 launch of Solana's V1.18 upgrade and the live deployment of Firedancer on the mainnet in non-voting mode significantly enhanced transaction scheduling and block production capabilities. 
The addition of Light Protocol and Helius's ZK Compression solution also aimed to address scaling, an area where Solana continues to make strides.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41690129/borderless-integrates-with-fireblocks-to-enhance-fiat-to-crypto-payment-capabilities">Borderless Integrates With Fireblocks To Enhance Fiat-to-Crypto Payment Capabilities</a>
&#8220;The real-time upgrades and attention to network efficiency are vital as Solana prepares to scale further,&#8221; says the report, suggesting that Solana's technical advances are setting it apart in the competitive landscape of blockchain networks.
Solana's DeFi sector has also seen robust growth, with a 26% rise in total value locked (TVL), reaching $5.7 billion. 
This development placed Solana ahead of Tron (CRYPTO: TRON) by the end of September and signals heightened DeFi activity on the network. 
Kamino, a DeFi protocol within Solana, saw notable growth, with its TVL hitting $1.5 billion, propelled by PayPal's USD stablecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PYUSD</a>) and other assets. 
"These TVL increases highlight a surging interest in DeFi products on Solana, particularly those focused on yielding higher returns," the report observes, adding that innovations such as Kamino's lending orderbook and spot leverage are set to bolster Solana's DeFi market presence.
In terms of adoption, stablecoin PYUSD marked a new milestone, ending Q3 with a 341% increase in circulating market cap on Solana. 
"Institutional interest isn't just a phase," the report emphasizes, "it reflects a broader shift where major financial entities view Solana as a reliable network for their blockchain ambitions."
As Solana moves into Q4, it continues to attract attention from both institutional and retail users, evident from its $71 billion market cap—an increase of 5% from the previous quarter. 
What&#8217;s Next: For a comprehensive look at how these developments impact the broader market, Benzinga's <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event on Nov. 19 offers timely insights.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41687739/nate-silver-says-kamala-harris-may-need-backup-plans-if-the-blue-wal-is-split-but-sees-the">Nate Silver Says Kamala Harris &#8216;May Need Backup Plans&#8217; If The &#8216;Blue Wall&#8217; Is Split But Sees The Race As &#8216;A Near Coin Flip&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ETH

$PYUSD

$SOL

Solana Sees $173M Funding Surge In Q3 Amid Rising Institutional Interest From PayPal, Visa, Franklin Templeton

Goldman Sachs analyst Caitlin Burrows maintains Safehold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAFE#NYSE">SAFE</a>) with a Buy and lowers the price target from $38 to $30.

SAFE

Goldman Sachs Maintains Buy on Safehold, Lowers Price Target to $30

Goldman Sachs analyst Eric Sheridan maintains Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) with a Neutral and raises the price target from $45 to $55.

RBLX

Goldman Sachs Maintains Neutral on Roblox, Raises Price Target to $55

Barclays analyst Manav Patnaik maintains WillScot Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WSC#NASDAQ">WSC</a>) with a Equal-Weight and lowers the price target from $44 to $40.

Barclays Maintains Equal-Weight on WillScot Holdings, Lowers Price Target to $40

Goldman Sachs analyst Will Nance maintains Robinhood Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) with a Neutral and lowers the price target from $25 to $22.

HOOD

Goldman Sachs Maintains Neutral on Robinhood Markets, Lowers Price Target to $22

Goldman Sachs analyst Lizzie Dove maintains Norwegian Cruise Line (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) with a Neutral and raises the price target from $24 to $29.

NCLH

Goldman Sachs Maintains Neutral on Norwegian Cruise Line, Raises Price Target to $29

RBC Capital analyst Brad Heffern maintains Equity Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQR#NYSE">EQR</a>) with a Outperform and lowers the price target from $83 to $79.

RBC Capital Maintains Outperform on Equity Residential, Lowers Price Target to $79

Goldman Sachs analyst Eric Sheridan maintains MediaAlpha (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAX#NYSE">MAX</a>) with a Buy and raises the price target from $20 to $26.

Goldman Sachs Maintains Buy on MediaAlpha, Raises Price Target to $26

Athira stock craters 72% on failed study for Alzheimer's drug

Athira Pharma (ATHA – Research Report) received a Hold rating and price target from BTIG analyst Thomas Shrader yesterday. The company's shares clo...

BTIG downgrades Athira Pharma (ATHA) to a Hold

Athira Pharma (ATHA – Research Report) received a Hold rating and price target from JMP Securities analyst Jason Butler today. The company's shares...

Athira Pharma (ATHA) was downgraded to a Hold Rating at JMP Securities

In a report released today, Paul Matteis from Stifel Nicolaus maintained a Hold rating on Athira Pharma (ATHA – Research Report), with a price targ...

Stifel Nicolaus Keeps Their Hold Rating on Athira Pharma (ATHA)

Athira plunges as Alzheimer's trial setback leads to downgrades

Athira Pharma (ATHA) has received a new Hold rating, initiated by JMP Securities analyst, Jason Butler. Jason Butler has given his Hold rating due ...

Athira Pharma: A Cautious Hold Amid Strategic Pivot and Clinical Progress

Jefferies analyst Andrew Tsai maintained a Hold rating on Athira Pharma (ATHA – Research Report) today and set a price target of $0.50. Andrew Tsai...

Hold Rating on Athira Pharma Amid Strategic Pivot and Clinical Uncertainty

Q3 pharma and biotech layoffs in charts: More than 1000 each in July and August

06:26 EDT Athira Pharma (ATHA) files $300M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving brea...

Athira Pharma files $300M mixed securities shelf

Athira Pharma (ATHA) announced that results from the Phase 2/3 LIFT-AD clinical trial of fosgonimeton to treat Alzheimer's disease will be presente...

Athira Pharma to present results from Phase 2/3 LIFT-AD trial

ABUS

ALPMF

ALPMY

ANTX

ATHA

BAYRY

BAYZF

BBIO

BMRN

CDTX

CRBU

CVAC

FGEN

GLYC

HLVX

IBRX

INAB

LXRX

PGEN

QURE

RAPT

RHHBY

RLAY

RPTX

SLRN

VIRX

Biotech

Press Releases

General

Athira Pharma to Participate in Upcoming June Conferences

Glancy Prongay & Murray LLP and Labaton Keller Sucharow LLP Announce Proposed Class Action Settlement on Behalf of Purchasers of the Publicly Traded Common Stock of Athira Pharma, Inc. - (NASDAQ: ATHA)

Athira Pharma Completes First Cohort in Phase 1 Clinical Trial of ATH-1105, an Oral, Small Molecule Drug Candidate for Amyotrophic Lateral Sclerosis (ALS)

Health Care

Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Health in Mild-to-Moderate Alzheimer's Disease Patients

Athira Pharma Announces Last Patient Completed LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer's Disease

Athira Pharma Presents Preclinical Data Demonstrating New Insights into the Mechanism by Which Fosgonimeton Protects Neurons from Alzheimer's Disease-Related Pathology at the Alzheimer's Association International Conference (AAIC) 2024

Earnings

Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates

Athira Pharma Announces Topline Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton for Mild-to-Moderate Alzheimer's Disease

Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases

Athira Pharma to Present Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Meeting

Comments

Athira Pharma

Vendite allo scoperto

Athira Pharma (NASDAQ:ATHA) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO